Totally agree. In addition to US, Japan update in coming months....

Totally agree. In addition to US, Japan update in coming months. I am more than happy for the price to stay in the doldrums till then. cheaper the better. very illquid stock. it will move up very quickly on positive news. Looking at CBL's peers few weeks ago.

European listed company Tobii's - Dynavox is the comparable subdivision to current state of CBL in AAC space. They do cheap AAC devices for kids with learning disabilities etc mainly.

Looking at the Tobii Annual Report if we just use that business divisions earning - 894 million Swedish Kroner as a guide ..... which makes up 62% of the total revenue - 1.42 B SEK revenue.

In Australian $ terms - Tobii Dynavox generates $132 million in revenue. Using that as a guide, if Tobii Dynavox was a standalone company it would be valued at $1.98 Billion .But also consider the fact that the company is valued so much despite 133 mil SEK or $20 mil Australian dollars loss. Operating margin range from 9-15%.

Another point to consider is they use generic Eye Tracking technology to make sales. No proprietary technology such as EMG or EOG.This moat and the fact that control bionics product development team is working in miniaturising their neuronode platform - cheaper and less bulky product with additional function like wheel chair control, they can go head to head with Tobii.

Control bionics valued at $40 odd million FD and making $3 mil in revenue and almost operating at cash flow positive state.